The key synthetic strategy involved hydrazonation of the precursor 1followed by subsequent reduction reaction of theenamino ester 2and intramolecular cyclization reaction to furnish the unprecedented 3,4-fused pyrazolidinone γ-lactam (4) in reasonable yield.The structureswere confirmed by spectroscopic methods and chemical transformation.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:A new pathway for the synthesis ofnovel 3,4-fused pyrazolidinone γ-lactam (4) starting from 2,3-dioxo-4-carboxy-5-(substituted)pyrrolidines (1) was developed.
📊
Key Findings & Data:A new pathway for the synthesis ofnovel 3,4-fused pyrazolidinone γ-lactam (4) starting from 2,3-dioxo-4-carboxy-5-(substituted)pyrrolidines (1) was developed.
💡
Conclusion & Impact:The key synthetic strategy involved hydrazonation of the precursor 1followed by subsequent reduction reaction of theenamino ester 2and intramolecular cyclization reaction to furnish the unprecedented 3,4-fused pyrazolidinone γ-lactam (4) in reasonable yield.The structureswere confirmed by spectroscopic methods and chemical transformation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
A new pathway for the synthesis ofnovel 3,4-fused pyrazolidinone γ-lactam (4) starting from 2,3-dioxo-4-carboxy-5-(substituted)pyrrolidines (1) was developed. The key synthetic strategy involved hydrazonation of the precursor 1followed by subsequent reduction reaction of theenamino ester 2and intramolecular cyclization reaction to furnish the unprecedented 3,4-fused pyrazolidinone γ-lactam (4) in reasonable yield.The structureswere confirmed by spectroscopic methods and chemical transformation.
🔖
Cite This Article
RASHİD, F. N. A. A., MOHAMMAT, M. F., SHAAMERİ, Z., HAMZAH, A. S. (2019). Synthesis of novel 3,4-fused pyrazolidinone γ-lactam bicyclic moieties from 2,3-dioxo-4-carboxy-5-(substituted)pyrrolidines. Organic Communications, Cilt: 12 - Sayı: 3, 121–131. https://ajindex.com/articles/288493
Biava, M.; Fioravanti, R.; Porretta, G. C.; Deidda, D.; Maullu, C.; Pompei, R. New pyrrole derivatives as antimycobacterial agents analogs of BM212. Bioorg.Med. Chem.Lett.1999, 9, 2983-2988. [2]Yee, N. K.; Nummy, L. J.; Byrne, D. P.; Smith, L. L.; Roth, G. P. Practical synthesis of an enantiomerically pure trans-4,5-disubstituted 2-pyrrolidinone via enzymatic resolution. Preparation of the LTB 4 inhibitor BIRZ-227. J. Org. Chem.1998, 63, 326-330. [3]Kashman, Y.; Koren-goldshlager, G.; Gravalos, G.; Schleyer, M. Halitulin, A new cytotoxic alkaloid from the marine sponge Haliclona tulearensis. Tetrahedron Lett. 1999, 40, 997-1000. [4]Komander, D.; Kular, G. S.; Schüttelkopf, A. W.; Deak, M.; Prakash, K. R. C.; Bain, J.; Elliot, M.; Garrido-Franco, M.; Kozikowsli, A. P.; Alessi, D. R.; Van Aalten, D. M. F.Interactions of LY333531 and other bisindolyl maleimide inhibitorswith PDK1.Structure2004, 12, 215-226. [5]Ma, K.; Wang, P.; Fu, W.; Wan,X.; Zhou, L.; Chu, Y.; Ye, D. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase. Bioorg. Med. Chem. Lett.2011, 21, 6724-6727. [6]Mohammat, M. F.; Najim, N.; Mansor, N. S.; Sarman, S.; Shaameri, Z.; Mat Zain, M.; Hamzah, A. S. Synthesis and bioactivity of some 2-oxo-5-aryl-3-hydrazone and 2-oxo-5-aryl-4-hydrazone pyrrolidine derivatives.Arkivoc2011, ix, 429-438. [7]Mohammat, M. F.; Shaameri,Z.; Hamzah, A. S. Synthesis of 2,3-dioxo-5-(substituted)arylpyrroles and their 2-oxo-5-aryl-3-hydrazone pyrrolidine derivatives.Molecules2009, 14, 250-256. [8]Mohammat, M. F.; Mansor, N. S.; Shaameri, Z.; Hamzah, A. S. Diastereoselective reduction of 2,3-dioxo-4-carboxy-5-substituted pyrrolidines using NaBH4/AcOH and heterogenous hydrogenation reactions.J. Korean Chem. Soc.2015, 59, 31-35. [9]Shaameri, Z.; Azib, N. A.; Mohammat, M. F.; Hamzah, A. S. Synthesis of 3,4-fused γ-lactone-γ-lactam bicyclic moieties as multi-functional synthons for bioactive molecules.J. Heterocycl. Chem.2015, 53, 1059-1064. [10]Han, C.; Guo, Y.-C.; Wang, D.-D.; Dai, X.-J.; Wu, F.-J.; Liu, H.-F.; Dai, G.-F.; Tao, J.-C. Novel pyrazole fused heterocyclic ligands: Synthesis, characterization, DNA binding / cleavage activity and anti-BVDV activity.Chinese Chem. Lett.2015, 26, 534-538. [11]Baldwin, J. E.; Freeman, R. T.; Schofield, C. Synthesis of a novel bicyclic γ-lactam analogue of the 1-oxapenams.Tetrahedron Lett.1989, 30, 4019-4020. [12]Novak, A.; Testen, A.; Bezenšek, J.; Grošelj, U.; Hrast, M.; Kasunič, M.; Gobec, S.; Stanovnik, B.; Svete, J